COMP <GO>
AEMD vs NMTC // EV/EBITDA & P/E VALUATION
Aethlon Medical Inc. (NASDAQ) VS. NeuroOne Medical Technologies Corporation (NASDAQ) • 15-METRIC TALLY: AEMD 2
— NMTC 1
■ METRIC PARITY
LAST: $5.52 (-0.54%) • MKT CAP: $8.9M
valuation
—
LAST: $0.97 (+12.96%) • MKT CAP: $8.8M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AEMD VS. NMTC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AEMD | NMTC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 56.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -46.50% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -39.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 163.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | NMTC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.6 | 40.1 | +11.50 | AEMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.9M | $8.8M | $23.8K | AEMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AEMD REV | NMTC REV | AEMD GROSS % | NMTC GROSS % | AEMD FCF | NMTC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $9.1M | — | 56.5% | -$7.0M | -$2.9M |
| FY 2024 | $0 | $3.5M | — | 31.3% | -$7.6M | -$11.1M |
| FY 2023 | $0 | $2.0M | — | — | -$10.1M | -$12.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AEMD // BETA —
NMTC // BETA —